In addition, the prevalence of NAFLD was higher among subjects with low sRAGE levels, supported by higher hepatorenal index, as well as a greater prevalence of elevated ALT. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.